Skip to main content
. 2014 Jan 23;145(5):1114–1120. doi: 10.1378/chest.13-1607

Table 3.

—Demographics, Clinical Characteristics, and Outcomes of Patients With P aeruginosa CAP by Admission to the ICU

No ICU (n = 266) ICU (n = 136)
Characteristic or Outcome Nonmacrolide (n = 156) Macrolide (n = 110) P Value Nonmacrolide (n = 75) Macrolide (n = 61) P Value
Age, y 76.2 ± 6.4 78.2 ± 6.3 .01 75.8 ± 6.8 76.0 ± 5.3 .8
Male sex 154 (98.7) 110 (100) .2 73 (97.3) 61 (100) .1
Married 84 (53.8) 57 (51.8) .7 33 (44.0) 36 (59.0) .08
Race
 White 131 (84.0) 98 (89.1) .2 55 (73.3) 54 (88.5) .02
 Black 9 (5.8) 6 (5.5) .9 10 (13.3) 5 (8.2) .3
Smoker 64 (41.0) 46 (41.8) .8 25 (33.3) 23 (37.7) .5
Alcohol abuse 8 (5.1) 4 (3.6) .5 3 (4.0) 3 (4.9) .7
Comorbid conditions
 Myocardial infarction 4 (2.6) 5 (4.5) .3 3 (4.0) 0 .1
 Chronic heart failure 25 (16.0) 21 (19.1) .5 10 (13.3) 13 (21.3) .2
 Peripheral vascular disease 19 (12.2) 11 (10.0) .5 10 (13.3) 8 (13.1) .9
 Cerebrovascular disease 22 (14.1) 9 (8.2) .1 13 (17.3) 12 (19.7) .7
 Dementia 4 (2.6) 6 (5.5) .2 3 (4.0) 4 (6.6) .5
 COPD 124 (79.5) 79 (71.8) .1 36 (48.0) 42 (68.9) .01
 Diabetes mellitus 29 (18.6) 20 (18.2) .9 21 (28.0) 14 (23.0) .5
 Diabetes with complications 4 (2.6) 6 (5.5) .2 7 (9.3) 8 (13.1) .4
 Neoplastic disease 26 (16.7) 26 (23.6) .1 19 (25.3) 11 (18.0) .3
 Metastatic disease 4 (2.6) 3 (2.7) .9 3 (4.0) 3 (4.9) .7
Charlson comorbidity index score 76.2 ± 6.4 78.2 ± 6.3 .5 2.3 ± 2.3 2.6 ± 2.3 .4
P aeruginosa antibiotic coverage 146 (93.6) 100 (90.9) .4 59 (78.7) 54 (88.5) .1
30-d mortality 17 (10.9) 12 (10.9) .9 21 (28.0) 20 (32.8) .5
Use of mechanical ventilation 58 (77.3) 44 (72.1) .4
Use of vasopressors 35 (46.7) 26 (42.6) .6
LOS 12.0 ± 16.5 10.8 ± 10.4 .5 37.7 ± 48.7 33.6 ± 32.2 .5

Data are presented as mean ± SD or No. (%). See Table 1 and 2 legends for expansion of abbreviations.